| Hospice Of The Big Horns 1401 W 5th Street, Sheridan, WY, 82801 | |
| (307) 672-1083 |
News Archive
Adjusting breast cancer therapy to individual patients to avoid ineffective treatment: Charité Universitätsmedizin Berlin and eleven partner institutions from six countries have set this as their goal. They have launched the EU research project RESPONSIFY.
Maybe you've had a reoccurring sore throat or frequent headaches. Perhaps the pain in your leg won't go away. In the past, you might have gone to a doctor's office to diagnose symptoms.
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3, and AC886, the active metabolite of quizartinib, compared with those of other FLT3 inhibitors.
Scientists from the Florida campus of The Scripps Research Institute have discovered a mechanism that plays a critical role in the formation of long-term memory. The findings shed substantial new light on aspects of how memory is formed, and could lead to novel treatments for memory disorders.
› Verified 3 days ago
| Name | Hospice Of The Big Horns |
|---|---|
| Location | 1401 W 5th Street, Sheridan, Wyoming |
| Hospice ID | 531510 |
| Category | Part of a hospital |
| Ownership Type | Government - County |
| Profit Type | GEVERNMENT |
| SSA county code | 160 |
News Archive
Adjusting breast cancer therapy to individual patients to avoid ineffective treatment: Charité Universitätsmedizin Berlin and eleven partner institutions from six countries have set this as their goal. They have launched the EU research project RESPONSIFY.
Maybe you've had a reoccurring sore throat or frequent headaches. Perhaps the pain in your leg won't go away. In the past, you might have gone to a doctor's office to diagnose symptoms.
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3, and AC886, the active metabolite of quizartinib, compared with those of other FLT3 inhibitors.
Scientists from the Florida campus of The Scripps Research Institute have discovered a mechanism that plays a critical role in the formation of long-term memory. The findings shed substantial new light on aspects of how memory is formed, and could lead to novel treatments for memory disorders.
› Verified 3 days ago
| NPI Number | 1144359423 |
| Organization Name | Memorial Hospital Of Sheridan County |
| Address | 1401 W 5th St Sheridan, Wyoming, 82801 |
| Phone Number | (307)672-1000 |
News Archive
Adjusting breast cancer therapy to individual patients to avoid ineffective treatment: Charité Universitätsmedizin Berlin and eleven partner institutions from six countries have set this as their goal. They have launched the EU research project RESPONSIFY.
Maybe you've had a reoccurring sore throat or frequent headaches. Perhaps the pain in your leg won't go away. In the past, you might have gone to a doctor's office to diagnose symptoms.
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3, and AC886, the active metabolite of quizartinib, compared with those of other FLT3 inhibitors.
Scientists from the Florida campus of The Scripps Research Institute have discovered a mechanism that plays a critical role in the formation of long-term memory. The findings shed substantial new light on aspects of how memory is formed, and could lead to novel treatments for memory disorders.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 93.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 76.7 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 96.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Adjusting breast cancer therapy to individual patients to avoid ineffective treatment: Charité Universitätsmedizin Berlin and eleven partner institutions from six countries have set this as their goal. They have launched the EU research project RESPONSIFY.
Maybe you've had a reoccurring sore throat or frequent headaches. Perhaps the pain in your leg won't go away. In the past, you might have gone to a doctor's office to diagnose symptoms.
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3, and AC886, the active metabolite of quizartinib, compared with those of other FLT3 inhibitors.
Scientists from the Florida campus of The Scripps Research Institute have discovered a mechanism that plays a critical role in the formation of long-term memory. The findings shed substantial new light on aspects of how memory is formed, and could lead to novel treatments for memory disorders.
› Verified 3 days ago
| Home Health Aides | 2 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Registered Nurses | 7 |
| Other Personnel | 3.5 |
| Total Employees | 15.5 |
|---|
News Archive
Adjusting breast cancer therapy to individual patients to avoid ineffective treatment: Charité Universitätsmedizin Berlin and eleven partner institutions from six countries have set this as their goal. They have launched the EU research project RESPONSIFY.
Maybe you've had a reoccurring sore throat or frequent headaches. Perhaps the pain in your leg won't go away. In the past, you might have gone to a doctor's office to diagnose symptoms.
Oncotarget Volume 11, Issue 11 reported that in this preclinical study, we characterized the binding affinity and selectivity of quizartinib, a small-molecule inhibitor of FLT3, and AC886, the active metabolite of quizartinib, compared with those of other FLT3 inhibitors.
Scientists from the Florida campus of The Scripps Research Institute have discovered a mechanism that plays a critical role in the formation of long-term memory. The findings shed substantial new light on aspects of how memory is formed, and could lead to novel treatments for memory disorders.
› Verified 3 days ago
| Hospice Of The Big Horns Location: 1401 W 5th Street, Sheridan, Wyoming, 82801 Phone: (307) 672-1083 |